新闻|股票|评论|外汇|债券|基金|期货|黄金|银行|保险|数据|行情|信托|理财|区块链|汽车|房产|科技|视频|博客
|直播|财道
|农金

简称:恒瑞医药 代码:600276


会计年度:2002-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
片剂122,109,500.0046,091,500.0076,018,000.0062.25
医药包装材料89,626,400.0062,694,100.0026,932,300.0030.04
原料药15,179,400.009,224,900.005,954,500.0039.22
针剂131,362,700.0039,076,800.0092,285,900.0070.25

会计年度:2001-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计634,268,900.00255,391,900.00--59.73
普药69,519,200.0060,456,400.009,062,800.0013.03
新药383,584,100.0062,053,600.00321,530,500.0083.82
医药包装材料158,068,400.00120,260,700.0037,807,700.0023.91
原料药23,097,100.0012,621,000.0010,476,100.0045.35

    8/8 转到